Human TIM-3 Antibody, R&D Systems™

TIM-3

Polyclonal

Unconjugated

Q8TDQ0

HAVCR2

Mouse myeloma cell line NS0-derived recombinant human TIM-3 Ser22-Arg200 Accession # Q8TDQ0

100 μg

Primary

Detects human TIM-3 in direct ELISAs and Western blots. In direct ELISAs, approximately 5% cross-reactivity with recombinant mouse (rm) TIM-3 is observed and less than 1% cross-reactivity with recombinant human TIM-1, rmTIM-1, and rmTIM-2 is observed.

Human

IgG

Western Blot, Flow Cytometry, Immunohistochemistry, CyTOF, Immunoassay, In Situ Hybridization (ISH)

LYOPH

Western Blot 0.1 ug/mL, Flow Cytometry 0.25 ug/10^6 cells, Immunohistochemistry 3-15 ug/mL, CyTOF-ready, Knockout Validated 1 ug/mL, Dual RNAscope ISH-IHC 3-25 ug/mL

CD366, FLJ14428, HAVcr-2, HAVCR2, hepatitis A virus cellular receptor 2, kidney injury molecule-3, KIM-3, SPTCL, T cell immunoglobulin mucin 3, T cell immunoglobulin mucin-3, T-cell immunoglobulin and mucin domain-containing protein 3, TIM 3, Tim-3, TIM3, TIM3 T-cell membrane protein 3, TIMD3, TIMD-3, TIMD3KIM-3

Goat

Affinity Purified

RUO

84868

Reconstitute at 0.2 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.